Note 11 - Stock-based Compensation (Tables)
|
6 Months Ended |
Jun. 30, 2023 |
Notes To Financial Statements [Abstract] |
|
Share-based Payment Arrangement, Option, Activity |
Stock option transactions for the six months ended June 30, 2023, and June 30, 2022, are summarized as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Six months ended June 30, 2023 |
|
|
|
|
|
|
Options (in thousands) |
|
|
Weighted average exercise price |
|
|
Weighted average remaining contractual life (years) |
|
Outstanding, beginning of period |
|
|
1,100 |
|
|
$ |
52.22 |
|
|
|
|
Granted |
|
|
215 |
|
|
9.93 |
|
|
|
|
Exercised |
|
|
— |
|
|
|
— |
|
|
|
|
Forfeited |
|
|
(124 |
) |
|
|
49.51 |
|
|
|
|
Outstanding, end of the period |
|
|
1,191 |
|
|
$ |
45.06 |
|
|
|
7.3 |
|
Exercisable, end of the period |
|
|
711 |
|
|
|
59.61 |
|
|
|
6.3 |
|
Vested and expected to vest, end of period |
|
|
1,105 |
|
|
$ |
46.74 |
|
|
|
7.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Six months ended June 30, 2022 |
|
|
|
|
|
|
Options (in thousands) |
|
|
Weighted average exercise price |
|
|
Weighted average remaining contractual life (years) |
|
Outstanding, beginning of period |
|
|
1,007 |
|
|
$ |
68.30 |
|
|
|
|
Granted |
|
|
375 |
|
|
|
18.50 |
|
|
|
|
Exercised |
|
|
(1 |
) |
|
16.25 |
|
|
|
|
Forfeited |
|
|
(104 |
) |
|
43 |
|
|
|
|
Outstanding, end of the period |
|
|
1,277 |
|
|
$ |
56.24 |
|
|
|
6.5 |
|
Exercisable, end of the period |
|
|
710 |
|
|
|
69.73 |
|
|
|
4.8 |
|
Vested and expected to vest, end of period |
|
|
1,192 |
|
|
$ |
56.19 |
|
|
|
6.4 |
|
|
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions |
The following table presents the weighted average assumptions that were used in the Black‑Scholes option pricing model to determine the fair value of stock options granted during the period, and the resulting weighted-average fair values:
|
|
|
|
|
|
|
|
|
|
|
Six months ended June 30, 2023 |
|
|
Six months ended June 30, 2022 |
|
Risk-free interest rate |
|
|
3.41 |
% |
|
|
2.07 |
% |
Expected dividend yield |
|
|
- |
|
|
|
- |
|
Expected volatility |
|
|
80.3 |
% |
|
|
82.9 |
% |
Expected life of options |
|
5 years |
|
|
5 years |
|
Grant date fair value |
|
$ |
6.57 |
|
|
$ |
12.28 |
|
|
Schedule of Share-based Payment Award, Options, Grants in Period |
The following table presents the vesting terms of options granted in the period:
|
|
|
|
|
|
|
|
|
|
|
Six months ended June 30, 2023 |
|
|
Six months ended June 30, 2022 |
|
|
|
Number of options (in thousands) |
|
|
Number of options (in thousands) |
|
3-year vesting (50%-25%-25%) |
|
|
49 |
|
|
|
28 |
|
4-year vesting (50%-16 2/3%-16 2/3%-16 2/3%) |
|
|
166 |
|
|
|
347 |
|
Total stock options granted in the period |
|
|
215 |
|
|
|
375 |
|
|
Share-based Payment Arrangement, Vesting and Redemption of the RSUs Granted |
No RSUs were granted in the six months ended June 30, 2022. The following table presents the vesting and redemption of the RSUs granted in the three months and six months ended June 30, 2023 and June 30, 2022.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Six months ended June 30, 2023 |
|
Six months ended June 30, 2022 |
|
|
Number of options (in thousands) |
|
Weighted average grant date fair value |
|
Number of options (in thousands) |
|
Weighted average grant date fair value |
|
Outstanding, beginning of period |
|
- |
|
$ |
- |
|
|
- |
|
$ |
- |
|
Granted |
|
38 |
|
|
9.90 |
|
|
- |
|
|
- |
|
Vested and redeemed |
|
(38 |
) |
|
(9.90 |
) |
|
- |
|
|
- |
|
Outstanding, ending of period |
|
- |
|
$ |
- |
|
|
- |
|
$ |
- |
|
|
Share-based Payment Arrangement, Expensed and Capitalized, Amount |
The Company recorded share-based payment expense related to stock options and RSUs as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended June 30, |
|
|
Six months ended June 30, |
|
|
|
2023 |
|
|
2022 |
|
|
2023 |
|
|
2022 |
|
Research and development |
|
$ |
271 |
|
|
$ |
537 |
|
|
$ |
923 |
|
|
$ |
1,483 |
|
General and administrative |
|
|
498 |
|
|
|
242 |
|
|
|
1,720 |
|
|
|
1,810 |
|
|
|
$ |
769 |
|
|
$ |
779 |
|
|
$ |
2,643 |
|
|
$ |
3,293 |
|
|